Amneal (AMRX) EVP Andrew S. Boyer Gifts 80,000 Shares

What Happened

• Andrew S. Boyer, Executive Vice President of Amneal Pharmaceuticals, reported gifting 80,000 shares on September 1, 2026. The transaction is coded as a gift (G); price per share reported as $0.00, so there were no proceeds from the transfer. The Form 4 was filed on September 2, 2026.

Key Details

• Transaction date: 2026-09-01 (reported on Form 4 filed 2026-09-02; Accession No. 0001628280-26-060179)
• Transaction type/code: Gift (G)
• Shares transferred: 80,000; Price per share: $0.00; Aggregate value reported: $0
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnote: F1 — gift to a trust for the benefit of certain family members; reporting person does not serve as trustee
• Timeliness: Filed the next day (within standard Form 4 reporting window), so not late

Context

• A gift is a transfer of ownership, not an open-market sale or purchase, and does not necessarily indicate the insider's view of the company’s prospects. The filing provides no stated motive for the transfer; the footnote indicates the recipient is a family-benefit trust and Boyer is not the trustee. Retail investors should treat gifts as administrative/estate-planning moves rather than signals of insider buying or selling momentum.